1. 10PEGFR T790M mutation in treatment-naïve tumor samples: Low frequency, evidence for interaction with EGFR TKI-sensitizing mutations and lack of clear predictive value. (16th September 2018) Authors: Imyanitov, E; Ivantsov, A; Lavdovskaia, E; Iyevleva, A; Mitiushkina, N; Bizin, I; Orlov, S; Togo, A; Moiseyenko, F; Levchenko, E Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 315PFGFR1 and CCND1 gene amplifications are associated with breast cancer resistance to aromatase inhibitors. (1st October 2019) Authors: Imyanitov, E; Kramchaninov, M; Akhapkina, T; Sokolova, T; Aleksakhina, S; Togo, A; Iyevleva, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP209 miR-190b-5p expression is a highly reliable discriminator between ER-positive and ER-negative breast cancer. (1st November 2019) Authors: Iyevleva, A; Bizin, I; Sokolenko, A; Venina, A; Anisimova, E; Holmatov, M; Romanko, A; Stepanov, I; Togo, A; Imyanitov, E Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗